91 related articles for article (PubMed ID: 10378781)
1. Evaluation of toxicity of beta-tethymustine, a new anticancer compound, in mice.
Ghosh M; Sadhu U; Bhattacharya S; Dutta S; Bhattacharya B; Sanyal U
Cancer Lett; 1999 Apr; 138(1-2):107-14. PubMed ID: 10378781
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of toxicity of cypenhymustine, a new anticancer compound, in mice.
Sadhu U; Ghosh M; Bhattacharya S; Dutta S; Das H; Sanyal U
Cancer Lett; 1994 Sep; 85(1):65-72. PubMed ID: 7923104
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
Samanta S; Pain A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antitumor efficacy and toxicity of novel 6-nitro-2-(3-chloropropyl)-1H-benz[de]isoquinoline-1,3-dione in vivo in mouse.
Mukherjee A; Dutta S; Sanyal U
J Cancer Res Ther; 2013; 9(3):442-6. PubMed ID: 24125980
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of beta-tethymustine, a new anticancer compound, in murine tumour models.
Ghosh M; Bhattacharya S; Sadhu U; Dutta S; Sanyal U
Cancer Lett; 1997 Oct; 119(1):7-12. PubMed ID: 18372515
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
8. Histological vis-a-vis biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt-ATP on experimental animal models.
Pal S; Sadhu AS; Patra S; Mukherjea KK
J Exp Clin Cancer Res; 2008 Nov; 27(1):68. PubMed ID: 19014472
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dimethoxydop-NU as a novel anti-tumor agent.
Mukherjee A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2007 Dec; 26(4):489-97. PubMed ID: 18365543
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
Bala A; Kar B; Haldar PK; Mazumder UK; Bera S
J Ethnopharmacol; 2010 May; 129(1):131-4. PubMed ID: 20307641
[TBL] [Abstract][Full Text] [Related]
13. Acanthus ilicifolius plant extract prevents DNA alterations in a transplantable Ehrlich ascites carcinoma-bearing murine model.
Chakraborty T; Bhuniya D; Chatterjee M; Rahaman M; Singha D; Chatterjee BN; Datta S; Rana A; Samanta K; Srivastawa S; Maitra SK; Chatterjee M
World J Gastroenterol; 2007 Dec; 13(48):6538-48. PubMed ID: 18161924
[TBL] [Abstract][Full Text] [Related]
14. The effect of a Titanocene Dichloride derivative, Ti IV (C5H5)(2) NCS(2), on the haematopoietic response of Ehrlich tumour-bearing mice.
Valadares MC; Queiroz ML
Eur J Pharmacol; 2002 Mar; 439(1-3):35-42. PubMed ID: 11937090
[TBL] [Abstract][Full Text] [Related]
15. In vivo anti-tumour activity of novel Quinazoline derivatives.
Alapati V; Noolvi MN; Manjula SN; Pallavi KJ; Patel HM; Tippeswamy BS; Satyanarayana SV
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(13):1753-64. PubMed ID: 23208959
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of anticancer activity of ethanol extract of Sesbania grandiflora (Agati Sesban) against Ehrlich ascites carcinoma in Swiss albino mice.
Sreelatha S; Padma PR; Umasankari E
J Ethnopharmacol; 2011 Apr; 134(3):984-7. PubMed ID: 21251969
[TBL] [Abstract][Full Text] [Related]
17. Hepatoprotective effect of acetone semicarbazone on Ehrlich ascites carcinoma induced carcinogenesis in experimental mice.
Islam F; Ali SM; Khanam JA
Asian Pac J Trop Biomed; 2013 Feb; 3(2):105-10. PubMed ID: 23593588
[TBL] [Abstract][Full Text] [Related]
18. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 'cypenhymustine', a new anticancer compound, in murine tumour models.
Sanyal U; Bhattacharya S; Sadhu U; Dutta S; Das H; Ghosh M
Cancer Lett; 1993 Jun; 70(1-2):1-6. PubMed ID: 8330289
[TBL] [Abstract][Full Text] [Related]
20. A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice.
Ghosh P; Sur B; Bag SP; Sur P
Tumour Biol; 1999; 20(1):44-51. PubMed ID: 9858874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
